VVZ-368

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameVVZ-368
Drug Alias NameVVZ-368
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsGlycine reuptake inhibitors
TargetsSerotonin 2a (5-HT2a) receptorGlycine transporters (GlyTs)
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivozon Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivozon Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A